Central Proteina Earnings Estimate
Central Proteina Earnings per Share Projection vs Actual
About Central Proteina Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Central Proteina earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Central Proteina estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Central Proteina fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.PT Central Proteina Prima Tbk, together with its subsidiaries, operates as an integrated aquaculture company in Indonesia and internationally. PT Central Proteina Prima Tbk was founded in 1980 and is headquartered in Jakarta Selatan, Indonesia. Central Proteina operates under Farm Products classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1780 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Central Stock
Central Proteina financial ratios help investors to determine whether Central Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Central with respect to the benefits of owning Central Proteina security.